Sickle Cell Disease Treatment Market is geared to grow at a CAGR of 12% from 2023 to 2032 | insightSLICE
The market for treatments for sickle cell disease was valued at US$ 900 million in 2021 and is projected to grow at a CAGR of 12% through 2032.
Currently, it appears that between 22 and 27 million people worldwide have sickle cell disease, and each year, 317,000 additional babies are born with the condition. The need for treating diseases related to blood plasma and other similar factors has increased, which has led to an expansion of the sickle cell market globally.
Currently, there are therapies for sickle cell disease that are available that provide supportive care and symptomatic relief.
Although bone marrow transplant is the only curative treatment for SCD, individuals over 16 years old are typically the only ones who receive it due to the substantial risks associated with bone marrow transplants in adults.
Access the sample report: https://www.insightslice.com/request-sample/711
The key players in the Global Sickle Cell Disease Treatment Market are:
CRISPR Therapeutics, Novartis AG, Pfizer Inc., GlycoMimetics, Inc., F. Hoffmann-La Roche AG, Bluebird Bio, Inc., Global Blood Therapeutics, Inc., Bristol-Myers Squibb, Emmaus Life Sciences, Inc., and others are the major competitors in the global market for the treatment of sickle cell disease.
To improve their market positions, all of the key competitors engage in competitive strategies such as product creation, collaboration, licensing agreements, acquisitions, mergers, and mergers.
Growth is expected due to below mentioned factors:
For patients with low hemoglobin levels, medical professionals advise rapid treatment methods. Hydroxyurea and blood transfusions are currently the mainstays of treatment for chronic SCD. The majority of patients who take hydroxyurea do so with prejudice.
The iron surcharge, blood-borne infections, fever, and adversely susceptible reactions from numerous organs are risks for patients receiving blood transfusions. 20% or more of sickle cell disease sufferers are reliant on blood transfusion.
It is assumed that the lack of cheaper alternatives will act as a barrier to the advancement of Sickle Cell disease treatment. During the projected period of 2022–2032, the market’s growth is anticipated to be stymied by the FDA’s strict endorsement guidelines for sickle cell disease drugs.
In the coming years, it is anticipated that this aspect would hasten the growth of the global sickle cell disease treatment market. During the forecast timeframe of 2022–2032, new sectors are anticipated to provide funding to the global sickle cell disease therapy market.
Read more about the report inclusions: https://www.insightslice.com/sickle-cell-disease-treatment-market
Market Report covering Global Sickle Cell Disease Treatment solutions:
The report for Global Sickle Cell Disease Treatment Market is a landmark document that will provide key insights into this vast market.
The years 2022 to 2032 are used as the forecast period for our report. The report will undertake into consideration major developments from leading companies involved in the Global Sickle Cell Disease Treatment Market.
We will also provide a general market overview with details like share market analysis, factors influencing market growth, plans, and market prediction. We can assure you that our reports will provide excellent data for competitors and investors who wish to make significant growth in their portfolio or market share.
Regional performance of Sickle Cell Disease Treatment Market
People with sickle cell disease are frequently of African, Middle Eastern, and South Asian heritage. Some of the variables anticipated to propel the global market include a surge in immigration, improved healthcare services, and a large population of people of African heritage present in other regions.
Because of supportive government policies, rising understanding and knowledge of haematological malignancies, greater investment, and improved healthcare infrastructure, developing markets like Nigeria, Ghana, South Africa, Brazil, Mexico, Saudi Arabia, and India are anticipated to experience lucrative growth over the forecast period.
Blood transfusions commanded the sickle cell disease market among therapies in 2017, holding a share of more than 44.0%. However, due to a robust pipeline and a number of encouraging medications launches over the projection period, pharmacotherapy is anticipated to dominate the market by 2023.
Proceed to purchase: https://www.insightslice.com/buy-now/711
Global Sickle Cell Disease Treatment Market Key Segments:
By Treatment Indication
- Sickle cell anaemia
- Sickle beta thalassemia
- Others
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Rest of APAC
- Middle East & Africa
- UAE
- South Africa
- Saudi Arabia
- Rest of MEA
- South America
- Brazil
- Rest of South America
Report will provide best assessment of sickle cell disease treatment market:
The report will identify various market segments for the treatment of sickle cell disease globally and provide a detailed analysis of the major rivals who have the lion’s share of the market. Market shares of well-known companies in the sickle cell disease sector will also be assessed in light of recent statistics.
The report also considers critical competition information from all companies active in the market for treatments for sickle cell disease, including strategic planning, product offers, significant advancements, business goals, and research activities.
In the analysis of the global market, the actors in the company’s distribution chain and cost structure in addition to their activities will be considered. In the product management section, the emphasis will be on all of the products covered by the companies that participate in the market for treatments for sickle cell disease.
The subsection on recent developments will also focus on recent business initiatives, such as preparations for product announcements, acquisitions, mergers, bilateral agreements, endorsements, and regional expansion in the market for treatments for sickle cell disease globally.
Related reports:
Global Electric Dental Handpiece Market: https://www.insightslice.com/electric-dental-handpiece-market
Global Digital Pathology Market: https://www.insightslice.com/digital-pathology-market
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
